SAN FRANCISCO--(BUSINESS WIRE)--Jan 12, 2026--
Owkin, an AI company on a mission to solve the complexity of biology, today announced that its interoperable Pathology Explorer AI agent will be included in the launch of Claude for Healthcare and Life Sciences (HCLS) by Anthropic. This marks the first time a highly specialized, world-leading biological agent trained primarily on multimodal patient data is accessible through the Model Context Protocol (MCP) to a broad audience of healthcare and life sciences professionals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112836381/en/
The collaboration enables seamless integration of Owkin's advanced pathology analysis capabilities into Claude's AI platform, making sophisticated biological intelligence accessible to healthcare organizations, pharmaceutical companies, and research institutions within their Claude workflows, without requiring system overhauls or proprietary process changes.
"I believe this agentic interoperability is the future of biopharma discoveries," said Thomas Clozel, M.D., CEO and co-founder of Owkin. "By making our best-in-class agents trained on patient data from the world's leading hospitals accessible through portals like Claude for HCLS, we're enabling the biggest healthcare organizations to accelerate their research in ways that weren't possible before. This is about putting patient data first when training AI and making that intelligence universally available to cure disease faster."
Pathology Explorer is part of Owkin’s K Pro community of agents for biology. This agent identifies and locates cell and tissue types, enabling spatially-aware analysis of patient tissue images. Using the agent, users can analyze tumors and their microenvironments and study inflammation patterns. Pathology Explorer enables the extraction of biomarkers from digitized pathology images to generate and validate hypotheses through cohort-level survival analysis — a critical capability for accelerating drug discovery, clinical trial design, and development of digital diagnostic tools. The agent leverages proprietary, best-in-class AI models that have been trained on patient histopathology data sourced from Owkin's network spanning over 800 hospitals from 104 healthcare centers, enabling it to deliver high-accuracy analysis.
Owkin MCP Integration Enables Seamless Access
Owkin has developed industry standard MCP encoding specifically designed to allow its proprietary K Pro agents to integrate seamlessly with Claude's interface. Pathology Explorer is the first agent from Owkin's interoperable agentic AI infrastructure for biology to be offered for external integration, demonstrating the company's commitment to building an open, API-first infrastructure that can serve as the universal foundation for advancing drug development.
Claude for Healthcare and Life Sciences is designed to accelerate preclinical R&D (including bioinformatics, protocol development, and literature synthesis), streamline clinical trial operations and data management, and support regulatory affairs and submission preparation. The integration of Owkin's Pathology Explorer extends these capabilities by enabling deep biological reasoning specifically trained on real patient data.
This is the third in a series of major announcements Owkin is unveiling, including agentic infrastructure for biology (Owkin's new interoperable agentic infrastructure for biopharma) and a strategic collaboration with NVIDIA to enhance OwkinZero, Owkin's biological large reasoning model.
About Owkin
Owkin is an AI company with $300 million in funding on a mission to solve the complexity of biology. It is building the first Biological Artificial Super Intelligence (BASI) by combining powerful biological large reasoning models, multimodal patient data, and agentic software. At the heart of this system is Owkin K, an AI copilot, and OwkinZero, Owkin's biological large reasoning model, used by researchers, clinicians, and drug developers to better understand biology, validate scientific hypotheses, and deliver better diagnostics and therapies faster. Owkin has exclusive access to multimodal patient data from more than 800 hospitals collected over a decade and partners with eight of the 10 largest pharmaceutical companies. For more information, visit www.owkin.com.
Owkin Media Kit:https://www.owkin.com/press-kit
Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences.
OKLAHOMA CITY (AP) — Shai Gilgeous-Alexander isn't scoring the way he usually does, but the Oklahoma City Thunder are still winning the way they normally do.
Gilgeous-Alexander, the reigning NBA MVP, averaged 31.1 points during the regular season. In the Western Conference semifinals against the Los Angeles Lakers, he is averaging 20 points and taking only 14 shots per game.
Oklahoma City has still won the first two games by an average of 18 points. Gilgeous-Alexander and Chet Holmgren each scored 22 points, and the defending champion Thunder beat the Lakers 125-107 on Thursday night.
Ajay Mitchell, starting in place of injured Jalen Williams, is averaging 19 points on 50% shooting in the series for Oklahoma City.
“I think the coaching staff does a good job at just getting all of us ready,” said Mitchell, a second-year guard. "And we have a lot of competitors. Like, everyone’s a competitor on our team. So every time the lights are bright, everyone’s ready to go.”
Holmgren is the leading scorer for the Thunder in the best-of-seven series with 23 points per game. The 2026 All-Star also is averaging 10.5 rebounds and 2.5 blocks.
Jared McCain, a midseason acquisition from the Philadelphia 76ers, barely played in the first round against Phoenix but has averaged 15 points and made 8 of 10 3-pointers in the series.
“He goes in there, stays in character, stays aggressive," Thunder coach Mark Daigneault said. "He’s going to shoot the next shot. He makes the right plays, plays inside the team. He competes defensively, has had good defensive possessions for us. And he was huge tonight. You need that in a playoff series.”
The Lakers again were without scoring champion Luka Doncic, who is out indefinitely with a strained left hamstring. They also were missing forward Jarred Vanderbilt, the reserve forward who dislocated the pinkie on his right hand during the second quarter of Game 1. The Lakers had three players finish with five fouls, limiting their aggressiveness late in the game.
Los Angeles guard Austin Reaves, who struggled with his shot in Game 1, scored 31 points on 10-for-16 shooting in Game 2. LeBron James, coming off a 27-point effort in Game 1, followed that up with 23.
With the Lakers up 63-61 early in the third quarter, Gilgeous-Alexander got tied up with Reaves and was called for his fourth foul. Upon review, it was upgraded to a flagrant 1 for Gilgeous-Alexander's follow through. Oklahoma City's Alex Caruso was called for a technical foul as the situation was being sorted out.
Gilgeous-Alexander left the game with the Lakers up 65-61, but the Thunder rallied and took control without him. On a fast break, Holmgren found a trailing Jaylin Williams, who hit a 3-pointer and was fouled. His free throw put the Thunder up 85-74.
The Thunder outscored the Lakers 32-15 while Gilgeous-Alexander was out in the third quarter to take a 93-80 lead into the fourth.
“It was amazing," Gilgeous-Alexander said. “They strung together stops, they’re playing the right way offensively and things are going their way. Full confidence in those guys. They know how to win basketball games. And we've proven that. They’ve proven that no matter who’s on the floor, they know how to get the job done. And they just did it again tonight."
The Lakers cut Oklahoma City's lead to five in the fourth quarter before the Thunder pulled away again.
Los Angeles will host Game 3 on Saturday.
“We just stuck with it,” Holmgren said. “It’s the game of basketball. It’s not always going to go your way. It’s about how you respond. And this team has proven many times that we know how to respond. And we did so tonight.”
This story has been corrected to show that Shai Gilgeous-Alexander is averaging 20, not 19, points per game against the Lakers.
AP NBA: https://apnews.com/hub/NBA
Oklahoma City Thunder's Chet Holmgren (7) shoots over Los Angeles Lakers' Austin Reaves (15) in the second half of Game 2 in a second-round NBA basketball playoffs series Thursday, May 7, 2026, in Oklahoma City. (AP Photo/Nate Billings)
Oklahoma City Thunder guard Ajay Mitchell, front, works for a shot as Los Angeles Lakers' Austin Reaves, rear, defends in the second half of Game 2 in a second-round NBA basketball playoffs series Thursday, May 7, 2026, in Oklahoma City. (AP Photo/Nate Billings)
Los Angeles Lakers' LeBron James stands on the court in the second half of Game 2 in a second-round NBA basketball playoffs series against the Oklahoma City Thunder Thursday, May 7, 2026, in Oklahoma City. (AP Photo/Nate Billings)
Oklahoma City Thunder guard Shai Gilgeous-Alexander (2) drives to the basket past Los Angeles Lakers' Deandre Ayton (5) and LeBron James, rear, in the second half of Game 2 in a second-round NBA basketball playoffs series Thursday, May 7, 2026, in Oklahoma City. (AP Photo/Nate Billings)
Oklahoma City Thunder center Chet Holmgren (7) works to the basket against Los Angeles Lakers forward Rui Hachimura (28) in the second half of Game 2 in a second-round NBA basketball playoffs series Thursday, May 7, 2026, in Oklahoma City. (AP Photo/Nate Billings)
